There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
A growing number of studies have investigated the efficacy of novel, adjunctive pharmacotherapies
for treatment of cognitive deficits in schizophrenia with conflicting results.